1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow astodrimer: new trials by email Literature Review of astodrimer trials Research Report on astodrimer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing. 3% SPL7013 Gel (VivaGel) - HIV Infections, HSV-2 Genital Herpes | Phase 1 / Phase 2 | Completed | Starpharma Pty Ltd | 12 | 2008-08-01 | 2018-10-30 |
HIV Infections (1)
Australia (1)